Cancer Science · 2010 · 78 citations · 24 references
Life SciencesOncologyPharmacologyApoptosisChemotherapyMolecular OncologyApoptosis In CancerApoptosis RegulationApoptosis ResistanceMicrorna BiologyMicrorna-mediated RegulationRna InterferenceApoptosis-regulating MicrornasApoptotic MorphologyMicrorna In ApoptosisMicrorna In CancerMicrorna Regulation Of ApoptosisMicrorna-mediated ResistanceSensitivityTraditional Chinese Medicine
Arsenic trioxide (ATO), an ancient traditional Chinese medicine, has been successfully used as a therapeutic agent for leukemia. Drug resistance and toxicity are major concerns with the treatment. MicroRNAs (miRNAs) are endogenous small non-coding RNA molecules that might modulate cellular sensitivity to anticancer drugs. miRNA-21 (miR-21) is one of the most prominent miRNAs involved in various aspects of human cancers. However, miR-21 has been rarely characterized in chronic myelogenous leukemia (CML). Here, we used a specific anti-miR-21 oligonucleotide (AMO-miR-21) to sensitize K562 cells to ATO by degradation of miR-21. The results showed that both AMO-miR-21 and ATO caused growth inhibition, apoptosis, and G1-phase arrest in K562 cells. Meanwhile, AMO-miR-21 significantly promoted ATO-mediated growth inhibition and apotosis without affecting the G1 phase. Apoptotic cells were confirmed morphologically with Giemsa's staining. Furthermore, dual-luciferase reporter vector, containing two tandem miR-21 binding sites from PDCD4 3'UTR, validated that PDCD4 was directly regulated by miR-21. Therefore, AMO-miR-21 sensitized leukemic K562 cells to ATO by inducing apoptosis partially due to its up-regulation of PDCD4 protein level. The combination of ATO and AMO-miR-21 present therapeutic potential for CML.
24
Prediction of Mammalian MicroRNA Targets
Benjamin P. Lewis, I‐hung Shih, Matthew W. Jones-Rhoades et al. · Cell · 2003 · 5.2K citations · Full text
miRBase: microRNA sequences, targets and gene nomenclature
Sam Griffiths‐Jones · Nucleic Acids Research · 2005 · 4.8K citations · Full text
Irfan A. Asangani, Suhail Ahmed Kabeer Rasheed, Dessislava A. Nikolova et al. · Oncogene · 2007 · 1.9K citations